Abstracts

IDENTIFICATION OF BROADLY NEUTRALIZING ANTIBODIES FROM SHIV-INFECTED CHINESE MACAQUES

Broadly neutralizing antibodies (bnAbs) have been obtained from HIV-1-infected individuals after 2-4 years of infection. However, bnAbs with similar breadth and potency have not been isolated from SHIV-infected rhesus macaques. Understanding how bnAbs develop in SHIV-infected non-human primates (NHPs) will have important implications in use of rhesus macaques to study efficacy of HIV-1 vaccines. Single…

INTEGRATED ANALYSIS OF MULTICELLULAR IMMUNE DYNAMICS DURING HYPERACUTE HIV INFECTION

Development of effective vaccines and therapeutics is facilitated by understanding the earliest moments of infection. Studies in S(H)IV models have characterized the quality and duration of the interferon-stimulated gene (ISG) response in acute infection. However, longitudinal immune responses to acute HIV infection are underexplored. Moreover, contributions and interactions of different cell subsets are unknown. Here,…

25-HYDROXYCHOLESTEROL INHIBITS HERPESVIRUSES BY ACTIVATING INFLAMMATORY PATHWAYS

Kaposi’s Sarcoma Herpesvirus (KSHV/HHV-8) expresses several viral products during latency and lytic replication cycle that block innate immune responses. It is therefore of interest to study antiviral approaches that can tip the balance and help the host mount an effective immune response. Recently, we have described how 25-hydroxycholesterol (25HC), a derivative of cholesterol, can block…

ANAL HPV INFECTIONS DO NOT ASSOCIATE WITH RECTAL HIV-RNA SHEDDING IN HIV+ PATIENTS

Rectal HIV-RNA shedding occurs in a not negligible proportion of HIV+ pts with undetectable plasma HIV-RNA. Since multiple HPV infections are often detected in anal swabs from HIV+ pts, a causal effect of HPV in triggering rectal HIV replication could be hypothesized. A cross-sectional, monocentric study was conducted, in which consecutively-enrolled, HIV+, virologically-suppressed pts undergoing…

HIGH-RISK HUMAN PAPILLOMAVIRUS ONCOPROTEINS DYSREGULATE INTERLEUKIN-1 SIGNALING

High-risk human papillomavirus (HPV) infection causes cervical, anogenital, and oropharyngeal cancers that account for ~5% of cancer cases worldwide. The incidence of these AIDS-defining (cervical) or non-AIDS-defining (anal, oropharyngeal) malignancies is increasing among HIV-infected individuals. A mutation in any one of several components of the interleukin-1 (IL-1) signaling pathway predisposes individuals to develop HPV-associated malignancies, suggesting…

OVERT GUT IL-32 ISOFORM EXPRESSION DURING TREATED HIV INFECTION: REGULATION BY IL-17A

The interplay between intestinal epithelial cells (IEC) and Th17 cells is key for mucosal immunity homeostasis. HIV infection provokes intestinal barrier function impairment and chronic immune activation, which are not normalized by antiretroviral therapy (ART). Such alterations coincide with the overexpression of IL-32, a newly described cytokine, with multiple isoforms. IL-32 overexpression was predictive of…